Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2023, 167(2):185-191 | DOI: 10.5507/bp.2022.039

Clinical presentation and pulmonary function tests in post-acute COVID-19 patients

Samuel Genzor1, Petr Jakubec1, Milan Sova1, 2, Jan Mizera1, Pavol Joppa3, Radim Burget4, Pavol Pobeha3
1 Department of Respiratory Diseases and Tuberculosis, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic
2 Department of Respiratory Diseases and Tuberculosis, University Hospital Brno and Faculty of Medicine and Dentistry, Masaryk University Brno, Czech Republic
3 Department of Respiratory Diseases and Tuberculosis, University Hospital and Faculty of Medicine and Dentistry, Pavol Jozef Safarik University, Kosice, Slovak Republic
4 Department of Telecommunications, University of Technology, Brno, Czech Republic

Aims: The study analysed post-acute COVID-19 symptoms and the pulmonary function test (PFT) results in patients surviving the native strain of the virus.

Methods: The study was prospective; the inclusion criteria were positive PCR test for SARS-CoV-2 and age 18-100. Exclusion criteria were active respiratory infection, known or suspicious pre-existing pulmonary disease, cardiac failure, recent or acute pulmonary embolism, anaemia, and neuromuscular diseases. The recruitment period was 1st March 2020 - 25th December 2020. The initial examination was performed 4-12 weeks after the disease onset. All subjects underwent physical examination, anamnesis, chest x-ray and PFT.

Results: The study involved 785 subjects (345 male) mean age 53.8 (SD 14.6). The disease severity groups were: mild (G1), moderate (G2) and severe/critical (G3). Anosmia was present in the acute disease phase in 45.2% of G1 patients, but only in 4.5% of G3 patients. Dyspnoea occurred frequently in more severe groups (40%, 51.8% and 63.7% for G1, G2 and G3 respectively), while cough and fatigue showed no relationship to disease severity. Females were more likely to experience persistent symptoms. PFT results were significantly decreased in more severe groups compared to the mild COVID-19 patients, diffusing capacity was 86.3%, 79% and 68% of predicted values in G1, G2 and G3 respectively.

Conclusion: Anosmia during the acute phase was associated with mild disease, persisting dyspnoea was more frequent after more severe COVID-19. Females tended to have persisting symptoms in post-acute phase more frequently. PFT results showed decrease with disease severity.

Keywords: COVID-19, post-acute phase, clinical presentation, pulmonary function tests

Received: June 4, 2022; Revised: August 16, 2022; Accepted: August 24, 2022; Prepublished online: September 6, 2022; Published: June 12, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Genzor, S., Jakubec, P., Sova, M., Mizera, J., Joppa, P., Burget, R., & Pobeha, P. (2023). Clinical presentation and pulmonary function tests in post-acute COVID-19 patients. Biomedical papers167(2), 185-191. doi: 10.5507/bp.2022.039
Download citation

References

  1. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. Bethesda (MD): National Institutes of Health (US); 2021. PMID: 34003615. [cited 2022 May 15] Available from: https://www.covid19treatmentguidelines.nih.gov.
  2. Purja S, Shin H, Lee JY, Kim E. Is loss of smell an early predictor of COVID-19 severity: a systematic review and meta-analysis. Arch Pharm Res 2021;44(7):725-40. doi: 10.1007/s12272-021-01344-4 Go to original source... Go to PubMed...
  3. Carfì A, Bernabei R, Landi F; Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA 2020;324(6):603-5. doi: 10.1001/jama.2020.12603 Go to original source... Go to PubMed...
  4. Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, Walshaw C, Kemp S, Corrado J, Singh R, Collins T, O'Connor RJ, Sivan M. Post-discharge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol 2021;93(2):1013-22. doi: 10.1002/jmv.26368 Go to original source... Go to PubMed...
  5. Wang X, Xu H, Jiang H, Wang L, Lu C, Wei X, Liu J, Xu S. Clinical features and outcomes of discharged coronavirus disease 2019 patients: a prospective cohort study. QJM 2020;113(9):657-65. doi: 10.1093/qjmed/hcaa178 Go to original source... Go to PubMed...
  6. Lopez-Leon, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, Villapol S. More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. medRxiv [Preprint]. 2021 Jan 30:2021.01.27.21250617. doi: 10.1101/2021.01.27.21250617. Update in: Sci Rep 2021;11(1):16144. doi: 10.1101/2021.01.27.21250617 Go to original source... Go to PubMed...
  7. Cares-Marambio K, Montenegro-Jiménez Y, Torres-Castro R, Vera-Uribe R, Torralba Y, Alsina-Restoy X, Vasconcello-Castillo L, Vilaró J. Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. Chronic Respir Dis 2021;18:14799731211002240. doi: 10.1177/14799731211002240 Go to original source... Go to PubMed...
  8. Fernández-de-Las-Peñas C, Guijarro C, Plaza-Canteli S, Hernández-Barrera V, Torres-Macho J. Prevalence of Post-COVID-19 Cough One Year After SARS-CoV-2 Infection: A Multicenter Study. Lung 2021;199(3):249-53. doi: 10.1007/s00408-021-00450-w Go to original source... Go to PubMed...
  9. Moreno-Pérez O, Merino E, Leon-Ramirez JM, Andres M, Ramos JM, Arenas-Jiménez J, Asensio S, Sanchez R, Ruiz-Torregrosa P, Galan I, Scholz A, Amo A, González-delaAleja P, Boix V, Gil J; COVID19-ALC research group. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J Infect 2021;82(3):378-83. doi: 10.1016/j.jinf.2021.01.004 Go to original source... Go to PubMed...
  10. Torres-Castro R, Vasconcello-Castillo L, Alsina-Restoy X, Solis-Navarro L, Burgos F, Puppo H, Vilaró J. Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysis. Pulmonology 2021;27(4):328-37.doi: 10.1016/j.pulmoe.2020.10.013 Go to original source... Go to PubMed...
  11. Huang Y, Tan C, Wu J, Chen M, Wang Z, Luo L, Zhou X, Liu X, Huang X, Yuan S, Chen C, Gao F, Huang J, Shan H, Liu J. Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase. Respir Res 2020;21(1):163. doi: 10.1186/s12931-020-01429-6 Go to original source... Go to PubMed...
  12. Frija-Masson J, Debray MP, Gilbert M, Lescure FX, Travert F, Borie R, Khalil A, Crestani B, d'Ortho MP, Bancal C. Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post-infection. Eur Respir J 2020;56(2):2001754. doi: 10.1183/13993003.01754-2020 Go to original source... Go to PubMed...
  13. Zhao Y, Yang C, An X, Xiong Y, Shang Y, He J, Qiu Y, Zhang N, Huang L, Jia J, Xu Q, Zhang L, Zhao J, Pei G, Luo H, Wang J, Li Q, Gao Y, Xu A. Follow-up study on COVID-19 survivors one year after discharge from hospital. Int J Infect Dis 2021;112:173-182. doi: 10.1016/j.ijid.2021.09.017 Go to original source... Go to PubMed...
  14. Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, Hallstrand TS, Kaminsky DA, McCarthy K, McCormack MC, Oropez CE, Rosenfeld M, Stanojevic S, Swanney MP, Thompson BR. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med 2019;200(8):70-88. doi: 10.1164/rccm.201908-1590ST Go to original source... Go to PubMed...
  15. Dalpiaz G, Cancellieri A. Alveolar Pattern. In: Dalpiaz, G., Cancellieri, A. (eds) Atlas of Diffuse Lung Diseases. Springer, Cham. 2017. https://doi.org/10.1007/978-3-319-42752-2_9. Go to original source...
  16. Stanojevic S, Kaminsky DA, Miller M, Thompson B, Aliverti A, Barjaktarevic I, Cooper BG, Culver B, Derom E, Hall GL, Hallstrand TS, Leuppi JD, MacIntyre N, McCormack M, Rosenfeld M, Swenson ER. ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J 2021:2101499. doi: 10.1183/13993003.01499-2021 Go to original source... Go to PubMed...
  17. Genzor S, Sova M, Mizera J, Jakubec P. COVID-19 related olfactory impairment - diagnostics, significance, and treatment. Cesk Slov Neurol N 2021;84(4):347-52. doi: 10.48095/cccsnn2021347 Go to original source...
  18. Mahil SK, Dand N, Mason KJ, Yiu ZZN, Tsakok T, Meynell F, Smith CH; PsoProtect study group. Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based study. J Allergy Clin Immunol 2021;147(1):60-71. doi: 10.1016/j.jaci.2020.10.007 Go to original source... Go to PubMed...
  19. González J, Benítez ID, Carmona P, Santisteve S, Monge A, Moncusí-Moix A, Gort-Paniello C, Pinilla L, Carratalá A, Zuil M, Ferrer R, Ceccato A, Fernández L, Motos A, Riera J, Menéndez R, Garcia-Gasulla D, Peñuelas O, Bermejo-Martin JF, Labarca G, Caballero J, Torres G, de Gonzalo-Calvo D, Torres A, Barbé F; CIBERESUCICOVID Project (COV20/00110, ISCIII). Pulmonary Function and Radiologic Features in Survivors of Critical COVID-19: A 3-Month Prospective Cohort Chest 2021;160(1):187-98. doi: 10.1016/j.chest.2021.02.062 Go to original source... Go to PubMed...
  20. Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, Kang L, Guo L, Liu M, Zhou X, Luo J, Huang Z, Tu S, Zhao Y, Chen L, Xu D, Li Y, Li C, Peng L, Li Y, Xie W, Cui D, Shang L, Fan G, Xu J, Wang G, Wang Y, Zhong J, Wang C, Wang J, Zhang D, Cao B. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 2021;397(10270):220-32. doi: 10.1016/S0140-6736(20)32656-8 Go to original source... Go to PubMed...
  21. Tirelli U, Franzini M, Valdenassi L, Pisconti S, Taibi R, Torrisi C, Pandolfi S, Chirumbolo S. Fatigue in post-acute sequelae of SARS-CoV2 (PASC) treated with oxygen-ozone autohemotherapy - preliminary results on 100 patients. Eur Rev Med Pharmacol Sci 2021;25(18):5871-75. doi: 10.26355/eurrev_202109_26809 Go to original source... Go to PubMed...
  22. Baniæ M, Jankoviæ Makek M, Samar¾ija M, Mur¹iæ D, Boras Z, Trke¹ V, Barièeviæ D, Kor¹iæ M, Basara L, Jalu¹iæ Glunèiæ T, Vukiæ Dugac A. Risk factors and severity of functional impairment in long COVID: a single-center experience in Croatia. Croat Med J 2022;63(1):27-35. doi: 10.3325/cmj.2022.27 Go to original source... Go to PubMed...
  23. Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, Pujol JC, Klaser K, Antonelli M, Canas LS, Molteni E, Modat M, Jorge Cardoso M, May A, Ganesh S, Davies R, Nguyen LH, Drew DA, Astley CM, Joshi AD, Merino J, Tsereteli N, Fall T, Gomez MF, Duncan EL, Menni C, Williams FMK, Franks PW, Chan AT, Wolf J, Ourselin S, Spector T, Steves CJ. Attributes and predictors of long COVID. Nat Med 2021;27(4):626-31. doi: 10.1038/s41591-021-01292-y Go to original source... Go to PubMed...
  24. Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. Kretzschmar MEE, editor. PLOS Med 2021;18(9):e1003773. doi: 10.1371/journal.pmed.1003773 Go to original source... Go to PubMed...
  25. Skala M, Svoboda M, Kopecky M, Kocova E, Hyrsl M, Homolac M, Chrobok V, Bostik P, Fajfr M, Prasil P, Plisek S, Sleha R, Koblizek V. Heterogeneity of post-COVID impairment: interim analysis of a prospective study from Czechia. Virol J 2021;18(1):73. doi: 10.1186/s12985-021-01546-8 Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.